期刊文献+

肺炎支原体感染与冠心病发生的相关性研究 被引量:7

Correction between Mycoplasma pneumoniae infection and coronary heart disease
原文传递
导出
摘要 目的探讨肺炎支原体(MP)感染与冠心病(CHD)发生的相关性及MP引起冠心病的致病机制,为临床诊治提供参考。方法将医院2011年1月-2012年1月收治的CHD患者45例作为观察组,另选取同期健康体检者45人为对照组,检测并比较两组患者MP抗体及总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)和高密度脂蛋白(HDL-C)等指标水平。结果观察组MP-IgG和MP-IgM阳性率分别为73.33%和62.22%,而CRP升高率为71.11%,对照组分别为37.78%、28.89%和24.44%,观察组明显高于对照组(P<0.05);冠心病组中MP-IgG阴性组患者TC、TG和LDL-C水平分别为(4.02±0.38)mmol/L、(1.21±0.22)mmol/L和(2.32±0.21)mmol/L,MP-IgG阳性组分别(5.89±0.45)mmol/L、(2.04±0.28)mmol/L、(3.43±0.27)mmol/L,MPIgG阴性组均明显低于MP-IgG阳性组,而MP-IgG阴性组患者HDL-C水平为(1.34±0.15)mmol/L,MP-IgG阳性组为(0.94±0.13)mmol/L,MP-IgG阴性组显著高于MP-IgG阳性组,两组比较差异有统计学意义(P<0.05)。结论 MP感染与冠心病的发生相关,可能与MP影响脂质代谢或通过炎症反应参与冠心病的病理过程有关。 OBJECTIVE To explore the relationship between Mycoplasma pneumoniae infection and coronary heart disease and discuss the pathogenesis of coronary heart diseases induced by M. pneumoniae. METHODS Totally 45 patients with coronary heart disease who were treated in the hospital from Jan 2011 to Jan 2012 were assigned as the observation group, while 45 healthy people who underwent physical examination were chosen as the control group, then the levels of the indicators including the M. pneumoniae antibodies, total cholesterol (TC),triacylg- lycerol (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were determined and compared between the two groups. RESULTS The positive rate of MP-IgG was 73.33% in the observation group, significantly higher than 37.78% in the control group;the positive rate of MP-IgM was 62.22% in the observation group, significantly higher than 28.89 %in the control group; the elevation rate of CRP was 71.11% in the observation group, significantly higher than 24.44% in the control group (P〈0.05). Of the patients with coronary heart diseases, the levels of TC, TG, and LDL of the patients with negative MP-IgG were respectively (4.02 ±0.38)mmol/L, (1.21±0. 22)mmol/L, and (2. 32±0. 21)mmol/L, significantly lower than (5. 89±0.45) mmol/L, (2. 044±0.28)mmol/L, and (3.43±0.27)mmol/L of the patients with positive MP-IgG; however, the level of HDL-C of the patients with negative MP-IgG was (1.34±0.15)mmol/L, significantly higher than (0.94 0.13)mmol/L of the patients with positive MP-IgG(P〈0.05). CONCLUSION The M. pneumoniae infection is associated with the incidence of coronary heart disease, which may be related to the impact of M, pneumoniae on lipid metabolism or the inflammation reactions' involving in pathogenesis of coronary heart disease.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第17期4253-4254,4257,共3页 Chinese Journal of Nosocomiology
基金 黄冈市科技计划基金资助项目(20090203)
关键词 肺炎支原体 冠心病 总胆固醇 甘油三酯 Mycoplasma infeetion Coronary heart disease Total cholesteroll Triacyglycerol
  • 相关文献

参考文献4

二级参考文献26

  • 1潘永瑜,刘芳,刘蓓菁.老年冠心病患者超敏C-反应蛋白水平与冠状动脉粥样硬化易损斑块检出情况分析[J].中国全科医学,2009,12(13):1209-1210. 被引量:33
  • 2Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:344
  • 3余峰,崔敏娴,黄金城,熊江波,姚冬莉,林飞进.中药协同治疗小儿肺炎合并全身炎症反应综合征的机制研究[J].中国中西医结合急救杂志,2006,13(5):276-278. 被引量:5
  • 4Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:117
  • 5Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation, 2006, 113:1708-1714.
  • 6Stumpf C,Petzi S, Seybold K, et al. Effect of atorvastatin versus rosuvastatin on levels of serum lipids,inflammatory markers and adiponectin in patients with hypercholesterolemia. Clin Sci, 2009,116 :45-52.
  • 7Fang C, Chen Y, Nie R, et al. Retrospective analysis of risk factors in young patients with coronary artery disease in Guangdong and Zhejiang, China [ J ]. Acta Cardiol, 2009,64 (2) : 195-199.
  • 8Azegami M, Hongo M, Yanagisawa S, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: a comparison with older patients [J]. Int Heart J, 2006,47(3) :343-350.
  • 9Huang Y, Hu Y, Mai W, et al. Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease [J]. Dis Markers, 2011,31 (5):295- 301.
  • 10Holvoet P, Vanhaecke J, Janssens S, et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease [J]. Circulation, 1998,98 (15) : 1487-1494.

共引文献289

同被引文献40

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部